Genomics and Personalized Medicine

基因组学和个性化医疗

基本信息

批准号：
9042805
负责人：
DAVID L. WOODLAND
金额：
$ 1.5万
依托单位：
KEYSTONE SYMPOSIA
依托单位国家：
美国
项目类别：
财政年份：
2016
资助国家：
美国
起止时间：
2016-01-01 至 2016-12-31
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/9042805
关键词：
Address Adult Alberta province Area Basic Science Big Data Biology Businesses Canada Cancer Patient Child Clinical Collaborations Computers DNA Sequence Data Development Disease Disease susceptibility Engineering Future Genome Genomics Goals Health Healthcare Human Individual Knowledge Learning Malignant Neoplasms Medicine Metagenomics Methodology Minor Outcome Patients Play Policies Proteomics Research Research Personnel Role Scientist Technology Translational Research Work cancer genome clinical practice disease diagnosis epigenomics genome sequencing human disease improved individualized medicine infancy interest meetings metabolomics new technology novel strategies personalized genomic medicine personalized health care personalized medicine posters precision medicine public health relevance sensor symposium technology development transcriptomics uptake

项目摘要

DESCRIPTION (provided by applicant): Support is requested for a Keystone Symposia meeting entitled Genomics and Personalized Medicine, organized by Michael Snyder, Leroy E. Hood and Heidi L. Rehm. The meeting will be held in Banff, Alberta, Canada from February 7-11, 2016. Genomics and other omics technologies are playing an increasingly important role in health care, and new sensors are being developed to help manage personal health. Spurred by the revolution in DNA sequencing technologies, it is now possible to sequence the genome of patients with cancer, undiagnosed disease and even healthy individuals to help tailor treatment for a specific individual's disease. This entire area is moving extremely rapidly in terms of technology, data, its management and analysis, and clinical uptake. The goal of this meeting is to bring together leaders in technology development, basic scientists, engineers and clinicians to advance human health. The conference intends to: 1) Help researchers and clinicians keep abreast of the latest developments; 2) Stimulate collaborations; and 3) Spur the development of new technologies that will improve personalized medicine. Opportunities for interdisciplinary interactions will be significantly enhanced by the concurrent meeting on The Cancer Genome, which will share a keynote address and three plenary sessions with this meeting.

描述（由申请人提供）：请求支持由 Michael Snyder、Leroy E. Hood 和 Heidi L. Rehm 组织的题为“基因组学和个性化医学”的 Keystone 研讨会。该会议将于 2 月 7 日在加拿大艾伯塔省班夫举行。 2016 年 -11 日。基因组学和其他组学技术在医疗保健中发挥着越来越重要的作用，在 DNA 测序革命的推动下，新的传感器正在开发中以帮助管理个人健康。随着技术的进步，现在可以移动癌症患者、未确诊疾病甚至健康个体的基因组，以帮助针对特定个体的疾病制定治疗方案，整个领域在技术、数据、管理和分析方面都非常迅速。此次会议的目标是汇集技术开发领域的领导者、基础科学家、工程师和倡导者，以促进人类健康：1) 帮助研究人员和民兵了解最新进展；2) 促进合作。 ; 和3) 刺激新技术的发展，改善个性化医疗同期举行的癌症基因组会议将大大增加跨学科互动的机会，该会议将与本次会议分享主题演讲和三场全体会议。